Direct activation of G-protein-gated inward rectifying K+ channels promotes nonrapid eye movement sleep
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
STUDY OBJECTIVES: A major challenge in treating insomnia is to find effective medicines with fewer side effects. Activation of G-protein-gated inward rectifying K+ channels (GIRKs) by GABAB agonists baclofen or γ-hydroxybutyric acid (GHB) promotes nonrapid eye movement (NREM) sleep and consolidates sleep. However, baclofen has poor brain penetration, GHB possesses abuse liability, and in rodents both drugs cause spike-wave discharges (SWDs), an absence seizure activity. We tested the hypothesis that direct GIRK activation promotes sleep without inducing SWD using ML297, a potent and selective GIRK activator. METHODS: Whole-cell patch-clamp recordings from hypocretin/orexin or hippocampal neurons in mouse brain slices were made to study neuronal excitability and synaptic activity; spontaneous activity, locomotion, contextual and tone-conditioned memory, and novel object recognition were assessed. Electroencephalogram/electromyogram (EEG/EMG) recordings were used to study GIRK modulation of sleep. RESULTS: ML297, like baclofen, caused membrane hyperpolarization, decreased input resistance, and blockade of spontaneous action potentials. Unlike baclofen, ML297 (5-10 µM) did not cause significant depression of postsynaptic excitatory and inhibitory currents (EPSCs-IPSCs), indicating preferential postsynaptic inhibition. ML297 (30 mg/kg, i.p.) inhibited wake activity and locomotion, and preferentially increased NREM sleep without altering EEG delta power, REM sleep, inducing SWDs, or impairing conditioned memory and novel object recognition. CONCLUSIONS: This study finds that direct activation of neuronal GIRK channels modulates postsynaptic membrane excitability and prolongs NREM sleep without changing sleep intensity, inducing SWDs, or impairing memory in rodents. These results suggest that direct GIRK activation with a selective compound may present an innovative approach for the treatment of chronic insomnia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid-β Dynamics Are Regulated by Orexin and the Sleep-Wake Cycle
Kang, J.-E., Lim, M. M., Bateman, R. J., Lee, J. J., Smyth, L. P., Cirrito, J. R., Fujiki, N., Nishino, S., & Holtzman, D. M. (2009) · Science · doi:10.1126/science.1180962 · Cited by 1,565
Morin, C. M., & Benca, R. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60750-2 · Cited by 976
Mice Lacking the TNF 55 kDa Receptor Fail to Sleep More After TNFα Treatment
Fang, J., Wang, Y., & Krueger, J. M. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-15-05949.1997 · Cited by 167
Self-citationWydeven, N., Marron Fernandez de Velasco, E., Du, Y., Benneyworth, M. A., Hearing, M. C., Fischer, R. A., Thomas, M. J., Weaver, C. D., & Wickman, K. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405190111 · Cited by 109 · cited 3×
“In addition, ML297 has shown anticonvulsant activity in mice induced by either pentylenetetrazole or electric shock [24, 56], and anxiolytic effects on anxiety-like behavior in mice [40].”
BackgroundSelf-citation
Research works printed but not linked: 52
- Kaczor, 2016, Prevalence and consequences of insomnia in pediatric population, Psychiatr Pol., 50, 555, 10.12740/PP/61226 · DOI
- Lane, 2017, Genome-wide association analyses of sleep disturbance traits identify new loci and highlight shared genetics with neuropsychiatric and metabolic traits, Nat Genet., 49, 274, 10.1038/ng.3749 · DOI · Paper page
- Angarita, 2016, Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review, Addict Sci Clin Pract., 11, 9, 10.1186/s13722-016-0056-7 · DOI · Paper page
- McCleery, 2016, Pharmacotherapies for sleep disturbances in dementia, Cochrane Database Syst Rev., 11, CD009178
- Porter, 2015, Sleep, cognition and dementia, Curr Psychiatry Rep., 17, 97, 10.1007/s11920-015-0631-8 · DOI
- Rodrigues, 2016, Pharmacological interventions for daytime sleepiness and sleep disorders in Parkinson’s disease: systematic review and meta-analysis, Parkinsonism Relat Disord, 27, 25, 10.1016/j.parkreldis.2016.03.002 · DOI
- Gilbert, 2015, Sleep disturbances, TBI and PTSD: implications for treatment and recovery, Clin Psychol Rev., 40, 195, 10.1016/j.cpr.2015.05.008 · DOI · Paper page
- Osorio, 2011, Greater risk of Alzheimer’s disease in older adults with insomnia, J Am Geriatr Soc., 59, 559, 10.1111/j.1532-5415.2010.03288.x · DOI · Paper page
- Vandrey, 2014, Interactions between disordered sleep, post-traumatic stress disorder, and substance use disorders, Int Rev Psychiatry., 26, 237, 10.3109/09540261.2014.901300 · DOI · Paper page
- Coffey, 2016, Reversal of the sleep-wake cycle by heroin self-administration in rats, Brain Res Bull., 123, 33, 10.1016/j.brainresbull.2015.09.008 · DOI
- Brower, 2010, Prevalence and correlates of withdrawal-related insomnia among adults with alcohol dependence: results from a national survey, Am J Addict., 19, 238, 10.1111/j.1521-0391.2010.00035.x · DOI · Paper page
- Maulik, 2002, Coping behaviors and relapse precipitants in opioid dependence: a study from North India, J Subst Abuse Treat., 22, 135, 10.1016/S0740-5472(02)00225-8 · DOI
- Raj, 2000, Relapse precipitants in opiate addiction: assessment in community treatment setting, Indian J Psychiatry., 42, 253
- Brannan, 2005, Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder, J Psychiatr Res., 39, 43, 10.1016/j.jpsychires.2004.04.011 · DOI · Paper page
- Brown, 2011, A review of sodium oxybate and baclofen in the treatment of sleep disorders, Curr Pharm Des., 17, 1430, 10.2174/138161211796197098 · DOI
- Richey, 2011, Pharmacological advances in the treatment of insomnia, Curr Pharm Des., 17, 1471, 10.2174/138161211796197052 · DOI · Paper page
- Scarff, 2015, Suvorexant for Adults with Insomnia, J S C Med Assoc., 111, 28
- Owen, 2016, Suvorexant: efficacy and safety profile of a dual orexin receptor antagonist in treating insomnia, Drugs Today (Barc)., 52, 29, 10.1358/dot.2016.52.1.2439940 · DOI
- Sutton, 2015, Profile of suvorexant in the management of insomnia, Drug Des Devel Ther., 9, 6035, 10.2147/DDDT.S73224 · DOI
- Szabadi, 2014, Selective targets for arousal-modifying drugs: implications for the treatment of sleep disorders, Drug Discov Today., 19, 701, 10.1016/j.drudis.2014.01.001 · DOI
- Monti, 2017, Zolpidem’s use for insomnia, Asian J Psychiatr., 25, 79, 10.1016/j.ajp.2016.10.006 · DOI
- Kaufmann, 2013, ML297 (VU0456810), the first potent and selective activator of the GIRK potassium channel, displays antiepileptic properties in mice, ACS Chem Neurosci., 4, 1278, 10.1021/cn400062a · DOI · Paper page
- Logothetis, 2015, Unifying mechanism of controlling kir3 channel activity by g proteins and phosphoinositides, Int Rev Neurobiol., 123, 1, 10.1016/bs.irn.2015.05.013 · DOI
- Logothetis, 1999, Gating of G protein-sensitive inwardly rectifying K+ channels through phosphatidylinositol 4,5-bisphosphate, J Physiol., 520 Pt 3, 630, 10.1111/j.1469-7793.1999.00630.x · DOI
- Xie, 1992, gamma-Hydroxybutyrate depresses monosynaptic excitatory and inhibitory postsynaptic potentials in rat hippocampal slices, Eur J Pharmacol., 223, 193, 10.1016/0014-2999(92)94839-N · DOI
- Black, 2009, The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy, Sleep Med., 10, 829, 10.1016/j.sleep.2009.05.004 · DOI
- Black, 2016, Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy, Sleep Med., 24, 57, 10.1016/j.sleep.2016.07.010 · DOI
- Black, 2014, GABAB agonism promotes sleep and reduces cataplexy in murine narcolepsy, J Neurosci., 34, 6485, 10.1523/JNEUROSCI.0080-14.2014 · DOI
- Roth, 2017, Effect of sodium oxybate on disrupted nighttime sleep in patients with narcolepsy, J Sleep Res., 26, 407, 10.1111/jsr.12468 · DOI
- Snead, 1992, Evidence for GABAB-mediated mechanisms in experimental generalized absence seizures, Eur J Pharmacol., 213, 343, 10.1016/0014-2999(92)90623-C · DOI · Paper page
- Stewart, 2009, Severity of atypical absence phenotype in GABAB transgenic mice is subunit specific, Epilepsy Behav., 14, 577, 10.1016/j.yebeh.2009.01.019 · DOI
- Ostojić, 2013, GABAB receptors as a common target for hypothermia and spike and wave seizures: intersecting mechanisms of thermoregulation and absence epilepsy, Neuroscience., 238, 39, 10.1016/j.neuroscience.2013.01.072 · DOI
- Muraki, 2004, Serotonergic regulation of the orexin/hypocretin neurons through the 5-HT1A receptor, J Neurosci., 24, 7159, 10.1523/JNEUROSCI.1027-04.2004 · DOI · Paper page
- Xie, 2008, Hypocretin/orexin and nociceptin/orphanin FQ coordinately regulate analgesia in a mouse model of stress-induced analgesia, J Clin Invest., 118, 2471
- Khroyan, 2012, Rodent motor and neuropsychological behaviour measured in home cages using the integrated modular platform SmartCage™, Clin Exp Pharmacol Physiol., 39, 614, 10.1111/j.1440-1681.2012.05719.x · DOI
- Dudhgaonkar, 2008, Synergistic interaction between meloxicam and aminoguanidine in formalin-induced nociception in mice, Eur J Pain., 12, 321, 10.1016/j.ejpain.2007.06.006 · DOI
- Kotecki, 2015, GIRK channels modulate opioid-induced motor activity in a cell type- and subunit-dependent manner, J Neurosci., 35, 7131, 10.1523/JNEUROSCI.5051-14.2015 · DOI · Paper page
- Radulovic, 1998, Generalization of fear responses in C57BL/6N mice subjected to one-trial foreground contextual fear conditioning, Behav Brain Res., 95, 179, 10.1016/S0166-4328(98)00039-4 · DOI
- Hicks, 2016, Voluntary wheel-running attenuates insulin and weight gain and affects anxiety-like behaviors in C57BL6/J mice exposed to a high-fat diet, Behav Brain Res., 310, 1, 10.1016/j.bbr.2016.04.051 · DOI
- Lueptow, 2017, Novel object recognition test for the investigation of learning and memory in mice, J Vis Exp, 10.3791/55718 · doi:10.3791/55718 · Paper page
- Xie, 2006, GABA(B) receptor-mediated modulation of hypocretin/orexin neurones in mouse hypothalamus, J Physiol., 574, 399, 10.1113/jphysiol.2006.108266 · DOI · Paper page
- Ladera, 2008, Pre-synaptic GABA receptors inhibit glutamate release through GIRK channels in rat cerebral cortex, J Neurochem., 107, 1506, 10.1111/j.1471-4159.2008.05712.x · DOI · Paper page
- Sarvey, 1989, Long-term potentiation: studies in the hippocampal slice, J Neurosci Methods., 28, 109, 10.1016/0165-0270(89)90016-2 · DOI
- Thompson, 1992, Comparison of the actions of adenosine at pre- and postsynaptic receptors in the rat hippocampus in vitro, J Physiol., 451, 347, 10.1113/jphysiol.1992.sp019168 · DOI · Paper page
- Qu, 2016, Automated monitoring of early neurobehavioral changes in mice following traumatic brain injury, Neural Regen Res., 11, 248, 10.4103/1673-5374.177732 · DOI
- Rajasekaran, 2014, Reduced locomotor activity correlates with increased severity of arthritis in a mouse model of antibody-induced arthritis, Open J Rheumat Autoimmune Dis, 4, 62, 10.4236/ojra.2014.41010 · DOI
- Shoji, 2014, Contextual and cued fear conditioning test using a video analyzing system in mice, J Vis Exp, 10.3791/50871 · DOI · Paper page
- Harashima, 2006, Abnormal expression of the G-protein-activated inwardly rectifying potassium channel 2 (GIRK2) in hippocampus, frontal cortex, and substantia nigra of Ts65Dn mouse: a model of Down syndrome, J Comp Neurol., 494, 815, 10.1002/cne.20844 · DOI · Paper page
- Marron Fernandez de Velasco, 2017, GIRK2 splice variants and neuronal G protein-gated K+ channels: implications for channel function and behavior, Scientific reports, 7, 1639, 10.1038/s41598-017-01820-2 · DOI
- Yi, 2001, Controlling potassium channel activities: interplay between the membrane and intracellular factors, Proc Natl Acad Sci USA, 98, 11016, 10.1073/pnas.191351798 · DOI
- Nagi, 2014, Kir3 channel signaling complexes: focus on opioid receptor signaling, Front Cell Neurosci., 8, 186, 10.3389/fncel.2014.00186 · DOI · Paper page
- Huang, 2018, GIRK1-mediated inwardly rectifying potassium current suppresses the epileptiform burst activities and the potential antiepileptic effect of ML297, Biomed Pharmacother., 101, 362, 10.1016/j.biopha.2018.02.114 · DOI
Cited by
Jeremic, D., Sanchez-Rodriguez, I., Jimenez-Diaz, L., & Navarro-Lopez, J. D. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107808 · Cited by 89
Neuronal G protein-gated K+ channels
Luo, H., Marron Fernandez de Velasco, E., & Wickman, K. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00102.2022 · Cited by 62
Advances in Targeting GIRK Channels in Disease
Zhao, Y., Gameiro-Ros, I., Glaaser, I. W., & Slesinger, P. A. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.12.002 · Cited by 44
Martinez, J. D., Brancaleone, W. P., Peterson, K. G., Wilson, L. G., & Aton, S. J. (2023) · Sleep · doi:10.1093/sleep/zsac301 · Cited by 11
Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery
Tanaka, M. (2026) · Biomedicines · doi:10.3390/biomedicines14061265
Metadata
- Authors
- Zou, B., Cao, W. S., Guan, Z., Xiao, K., Pascual, C., Xie, J., Zhang, J., Xie, J., Kayser, F., Lindsley, C. W., Weaver, C. D., Fang, J., & Xie, X. (.
- Venue
- Sleep
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-12-11
- Volume
- 42
- Issue
- 3
- ISSN
- 0161-8105 (ISSN-L)
- 1550-9109
- OpenAlex
- W2905518523
- Cited by
- 15
- References
- 4
- FWCI
- 0.69
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Funders
- National Institutes of Health (R43 HL142315, R42 HL084990, R44 AG043203, R44 NS086343)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Direct activation of G-protein-gated inward rectifying K+ channels promotes nonrapid eye movement sleep. https://app.cochat.ai/papers/10.1093/sleep/zsy244
- The paper
- Zou, B., Cao, W. S., Guan, Z., Xiao, K., Pascual, C., Xie, J., Zhang, J., Xie, J., Kayser, F., Lindsley, C. W., Weaver, C. D., Fang, J., & Xie, X. (. (2019). Direct activation of G-protein-gated inward rectifying K+ channels promotes nonrapid eye movement sleep. Sleep. https://doi.org/10.1093/sleep/zsy244
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.